Phospholipase C (PLC) enzymes are essential in regulating several important cellular functions in eukaryotes, including yeasts. In this study, PCR was used to identify a gene encoding PLC activity in Candida albicans, using oligonucleotide primers complementary to sequences encoding highly conserved amino acid regions within the X domains of previously characterized eukaryotic phospholipase C genes. The nucleotide sequence of the C. albicans gene, CAPLC7 (2997 bp), was determined from a recombinant clone containing C. albicans 132A genomic DNA; it encoded a polypeptide of 1099 amino acids with a predicted molecular mass of 124.6 kDa. The deduced amino acid sequence of this polypeptide (CAPLC1) exhibited many of the features common to previously characterized PLCs, including specific X and Y catalytic domains. The CAPLCl protein also exhibited several unique features, including a novel stretch of 18-19 amino acid residues within the X domain and an unusually long N-terminus which did not contain a recognizable EFhand Ca2+-binding domain. An overall amino acid homology of more than 27% with PLCs previously characterized from Saccharomyces cerewisiae and Schizosacchammyces pombe suggested that the CAPLCl protein is a &form of phosphoinositide-specif ic PLC (PI-PLC). PLC activity was detected in cell-free extracts of both yeast and hyphal forms of C. albicans 132A following 7 h and 24 h growth using the PLC-specific substrate p-nitrophenylphosphorylcholine (p-NPPC). In addition, CAPL C7 mRNA was detected by reverse transcriptase PCR in both yeast and hyphal forms of C. albicans 132A a t the same time intervals. Expression of CAPLCl activity was also detected in extracts of Escherichia coli DH5a harbouring plasmids which contained portions of the CAPLC7 gene lacking sequences encoding part of the N-terminus. Southern hybridization and PCR analyses revealed that all C. albicans and Candida dubhiensis isolates examined possessed sequences homologous to CAPLC7. Sequences related to
INTRODUCTION
The incidence of opportunistic infections caused by species of the genus Candida has increased dramatically over the last two decades, especially in immunocompromised patients. These include individuals infected with the human immunodeficiency virus (HIV), patients with AIDS and those undergoing chemotherapy or immunosuppressive therapy. In HIV-infected patients candidal infections are largely confined to the oral cavity and the oesophagus, whereas systemic candidosis is more common in patients with neutropaenia . Candida albicans is the predominant Candida species responsible for candidosis, although the incidence of infection caused by other species of Candida has increased (Sullivan et al., 1996) .
Phospholipases play important roles in regulating a variety of cellular functions in mammalian cells and in lower eukaryotes, including yeasts and slime moulds. Five kinds of phospholipase activity have been described for C. albicans, including phospholipase A (Costa et al., 1968; Pugh & Cawson, 1975 Price & Cawson, 1977; Barrett-Bee et al., 1985) ; phospholipase B (Banno et al., 1985; Ibrahim et al., 1995 Ibrahim et al., ,1996 ; phospholipase C (PLC) (Costa et al., 1968; Pugh & Cawson, 1977) ; lysophospholipase (Pugh & Cawson, 1975 Price & Cawson, 1977; Banno et al., 1985) and lysophospholipase-transacylase (Takahashi et al., 1991 ; Mirbod et al., 1995; Ibrahim et al., 1995) . Phosphoinositide-specific phospholipase C enzymes (PI-PLCs) play a pivotal role in receptor-linked signalling at the plasma membrane of eukaryotic cells. Hydrolysis of inositol phospholipids, particularly phosphatidylinositol-4,5-bisphosphate (PIP,) by PI-PLCs results in the formation of secondary messenger molecules, sn-1,2-diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP,), which are important in the regulation of many cellular functions (Berridge, 1993) . IP, causes the releases of Ca2+ ions from internal reserves and DAG activates protein kinase C (PKC) . Calcium mobilization and PKC activation are essential for many cellular activities, including secretion, cell growth and proliferation (Nishizuka, 1992 ; Mitchell, 1992) . PI-PLCs have been categorized into three subfamilies, B,-y and 6, with two to four isoforms in each. These enzyme subfamilies each contain two well-conserved amino acid regions, designated the X and Y domains, which are essential for enzyme activity (Ellis et al., 1993 ; Yagisawa et al., 1994) . Although the overall similarity between subfamilies is low, enzymes from each of the three subfamilies can be distinguished by their primary amino acid structure and molecular size (Rhee et al., 1989) . The 6 isoenzymes are the smallest and simplest PI-PLCs as they contain only sequences common to all PI-PLC subfamilies and are common to all eukaryotes, from yeasts and moulds to plants and mammals. In the yeasts Saccharomyces cerevisiae and Schixosaccharornyces pombe 6-type PI-PLCs are essential for growth and they are thought to be involved in relaying different nutritional and stress-related signals (Yoko-o et al., 1993 ; Fankhauser et al., 1995) .
T o date there have been no published reports describing the genetic characterization of determinants encoding PI-PLC enzymes from any Candida species. Because PIPLCs have a central function in plasma membrane receptor-linked signalling in eukaryotic cells, including yeasts and slime moulds, it is highly likely that these enzymes perform a similar function in C . albicans and other Candida species. The purpose of the present study was to clone and characterize a PI-PLC genetic determinant from C. albicans and to investigate whether similar determinants are present in a number of other Candida species. Here we report the molecular cloning and characterization of a PI-PLC genetic determinant (CAPLCI) from C. albicans and demonstrate expression of the gene in both the yeast and hyphal forms of the organism. The deduced amino acid sequence encoded by CAPLCI exhibits organizational features common to a wide variety of PI-PLC proteins from a diverse range of eukaryotic species but also shows unique features. We also report the presence of sequences homologous to CAPLC in several Candida species other than C. albicans, including Candida dubliniensis, Candida glabrata, Candida parapsilosis and Candida tropicalis.
METHODS
Candida strains, clinical isolates and culture media. The reference Candida strains used in this study were C. albicans 132A (Gallagher et al., 1992) ; C. dubliniensis CD48-I and CD46 ; C. lusitaniae NCPF 3156; and C. krusei NCPF 3321 ; the last two strains were obtained from the National Collection of Pathogenic Fungi (UK). The oral isolates used in the study included 15 C. albicans, 10 C. dubliniensis , 11 C. glabrata, five C. tropicalis, two C. parapsilosis and one isolate each of C. kefyr and C. guillerrnondii, each from separate AIDS patients with oral candidosis. Twelve C. albicans oral carriage isolates from HIV-negative normal healthy individuals were also included. The yeasts were routinely grown on Potato Dextrose agar (PDA, Oxoid) at pH 5.6 for 48 h at 37 "C. For liquid culture, Candida isolates and strains were routinely grown in Yeast Peptone Dextrose broth [YPD; (1-l) 10 g yeast extract (Oxoid), 20 g peptone (Difco), 20 g glucose, pH 5-51 at 37 "C in an orbital incubator (Gallenkamp) set at 180 r.p.m. The identity of each isolate was confirmed by their substrate assimilation patterns using the API ID 32C yeast identification system (bioMCrieux), according to the manufacturer's instructions. The assimilation profiles of each isolate were examined on at least three separate occasions using different batches of ID 32C kits. Germ tube and chlamydospore tests were carried out on each isolate using the methods described by Sullivan et al. (1995) . The identity of C. dubliniensis isolates was confirmed as described previously (Sullivan et al., 1995 (Sullivan et al., , 1996 .
Bacterial strains and culture media. Escherichia coli DH5a (Sambrook et al., 1989) was used as the host strain for plasmid pBluescript I1 KS( -) (Stratagene) and its recombinant derivatives and was maintained on LB agar (Sambrook et al., 1989) containing 100 pg ampicillin ml-' (LA medium). Plasmid DNA was transformed into competent CaC1,-treated DH5a cells using the procedure described by Sambrook et al. (1989) .
Following transformation, cells were plated immediately on to LA medium containing 100 pg X-Gal (Boehringer Mannheim) ml-' and 1 mM IPTG (Boehringer Mannheim) and trans-formants were selected using blue-white selection as described by Sambrook et al. (1989) . For liquid culture, strains harbouring plasmids were routinely grown in LB broth (Sambrook et al., 1989) containing 100 pg ampicillin ml-l at 37 "C in an orbital incubator (Gallenkamp) set at 180 r.p.m. Derivatives of DH5a harbouring recombinant plasmids pDB008, pDBOO9, pDBO10, pDB016 or pDB017 were grown in LB broth both with and without X-Gal (100 pg ml-l) and IPTG (1 mM) for use in PLC expression studies and were routinely maintained on LA agar medium. Large-and smallscale E. coli plasmid DNA preparations were performed as described by Sambrook et al. (1989) . The procedures used for the preparation of lambda phage stocks and the isolation of lambda phage DNA from E. coli phage lysates were as described by Sambrook et a1 (1989) . E . coli strain LE 392 (Sambrook et al., 1989) and its P2 phage lysogenic derivative, P2 393 (Sambrook et al., 1989) , were used for propagating the bacteriophage lambda cloning vector EMBL3 (Promega) and its recombinant derivatives, respectively, on LB medium supplemented with 10 mM MgSO, and 0.2% (w/v) maltose as described by Sambrook et al. (1989) . For liquid culture, organisms for phage infection were routinely grown in LB medium containing 10 mM MgSO, and 0 2 % (w/v) maltose at 37 "C in an orbital incubator (Gallenkamp) set at 180 r.p.m. Chemicals, enzymes and radioisotopes. Analytical-grade or molecular-biology-grade chemicals were purchased from Sigma, BDH or Boehringer Mannheim. [a-32P]dATP (3000 Ci mmol-l; 110 TBq mmol-') was purchased from Amersham. Restriction endonucleases, T4 DNA ligase (3000 Weiss units rnl-'), Klenow DNA polymerase (SO00 units ml-'), RNase-free DNase (10000 units ml-l) and Taq DNA polymerase (5000 units ml-') were purchased from Promega or from Boehringer Mannheim and were used according to the manufacturer's instructions. DNA hybridization. Probe DNA used in Southern hybridization experiments was labelled with [ c~-~~P ]~A T P (3000 Ci mmol-l; 110 TBq mmol-l) by the use of a random hexanucleotide primer labelling kit (Prime-a-Gene, Promega) , which was used according to the manufacturer's instructions. Membrane filters containing bound DNA were processed under conditions of high stringency ( > 60 "C) as described by Sambrook et al. (1989) , using a rotary hybridization oven (Hybaid). Isolation of genomic DNA for hybridization analysis and PCR. Total cellular DNA from Candida isolates was prepared according to the method described by Sullivan et al. (1995) . Restriction-endonuclease-generated fragments were separated by electrophoresis through 0 8 ' / o (w/v) horizontal agarose gels using 0.5xTBE buffer (Sambrook et al., 1989) as the electrophoresis buffer for 15 h at 2 V cm-'. Following electrophoresis, DNA fragments were transferred to MagnaGraph nylon membrane filters (MSI) by the method of Southern (1975) . Hybridization experiments were repeated on at least two occasions with separate preparations of genomic DNA.
PCR. Two degenerate PCR primers, termed CAPHOS and CAPH06, respectively (Table l) , were designed which were complementary to DNA sequences encoding two highly conserved amino acid regions within the X domain of 22 previously characterized PLC proteins from seven separate eukaryotic species (Table 2) . One of these degenerate primers (CAPHOS) consisted of a 26 bp forward primer complementary to a sequence encoding the conserved amino acid sequence SSHNTYL, which also included the 6 bp recognition sequence for the restriction endonuclease EcoRI at the 5' end. The reverse primer (CAPH06) consisted of a 43 bp oligonucleotide which was complementary to a sequence encoding the amino acid sequence GCRC(I/V)E(L/I)D(C/V)W(D/N)G and which also included the 6 bp recognition sequence for the restriction endonuclease XbaI at the 5' end. PCR amplification was performed in a 100 pl reaction mixture containing 60 pmol each of the forward and reverse primers, 1OmM deoxynucleoside triphosphates, 2.5 mM MgCl,, 10 mM Tris (pH 9.0 at 25 "C), 50 mM KC1, 0.1 YO (v/v) Triton X-100, 2-5 U Taq DNA polymerase and 500 ng C. albicans 132A total cellular DNA. PCR reactions were performed in a DNA thermal cycler (Perkin Elmer Cetus) with 35 cycles of 1 min at 94 "C, 2 min at 37 "C and 3 min at 72 "C. To complete the last cycle of amplification, the mixture was incubated for 10 min at 72 "C. Following amplification, 10 pl aliquots of each PCR mixture was subjected to agarose gel electrophoresis using 0.5 x TBE buffer through either 2% (w/v) low-EEO agarose (Sigma) or 2% (w/v) Seakem agarose (FMC) gels containing 0.5 pg ethidium bromide ml-' and the amplimers viewed on a UV transilluminator (UVP) . Experiments were repeated on at least two occasions with separate preparations of target genomic DNA. Cloning of PCR products. Individual PCR products were separately purified from Seakem agarose gels following electrophoresis by excising the appropriate portion of agarose into a sterile 1.5 ml Eppendorf microcentrifuge tube containing 500 pl sterile distilled water followed by boiling for 5 min. Three microlitres of this extract were then used as a DNA template for further PCR experiments as before except that annealing temperatures of 42 "C and 45 "C were used instead of 37 "C. These higher annealing temperatures ensured that only single PCR products were subsequently amplified. These were purified immediately following amplification by extraction with an equal volume of phenol/chloroform (1 : 1, v/v) followed by precipitation with 0.3 M sodium acetate and 2 vols ice-cold 100% (v/v) ethanol. Aliquots of each purified PCR product were then co-digested with EcoRI and XbaI and cloned into EcoRI-and XbaI-cleaved vector plasmid pBluescript .
DNA sequencing. DNA sequencing was performed by the dideoxy chain-termination method of Sanger et al. (1977) as described by Sambrook et al. (1989) using an automated Applied Biosystems 370A DNA sequencer and fluorescentdye-labelled primers (FLASH kit, Genpak) . Searches of the EMBL and GenBank databases for nucleotide and amino acid sequence similarities were performed using the BLAST family of computer programs (Altschul et al., 1990) . Protein sequence analysis was performed using the programmes within the GCG Wisconsin package (Genetics Computer Group, 1994) . Purification of C. albicans 132A cellular DNA for library construction. High-molecular-mass total cellular DNA from C. albicans strain 132A was isolated using a modification of the method described by Sullivan et al. (1995) as follows. After zymolyase treatment, the resulting spheroplasts were harvested and washed once in TE buffer and resuspended in 1 ml of 25 YO (w/v) sucrose in 50 mM Tris/HCl, 1 mM EDTA at pH 8.0. This solution was incubated at 37 "C for 10 min and then transferred to ice followed by the addition of 2 mg proteinase K and then 400 p10.5 M EDTA, pH 8.0, and 250 pl 10 % (w/v) sodium N-lauroyl sarcosinate. After thorough mixing, the spheroplast suspension was incubated on ice for 90 min, after which it was transferred to a shaking waterbath at 50 "C and incubated for 16 h. Following incubation, to each lysate was added 8 ml of a CsCl solution consisting of 69.9 g CsCl, 55-2 ml TE buffer and SO pg PMSF ml-'. This mixture was then transferred into 10 ml Quickseal ultra-clear cen-trifuge tubes (Beckman) and centrifuged for 40 h at 160000 g at 10 "C in a Beckman 70.1 Ti fixed-angle rotor using an L8-60M ultracentrifuge (Beckman). After centrifugation, DNA was collected from the tubes by side-puncture with an 18 gauge syringe needle (Microlance 2, Becton-Dickson) .
Caesium chloride was removed from the DNA by dialysis overnight (16 h) against 5 litres 1 x TE buffer at 4 "C using dialysis tubing (Sigma). DNA was recovered by ethanol precipitation, dried, resuspended in TE buffer at pH 8.0 and stored in aliquots at -20 "C. Construction of a C. albicans 132A genomic DNA library. A lambda EMBL3 library was constructed by ligating Sau3A-generated partial digest products of C. albicans 132A chromosomal DNA greater than 10 kb in size with BamHI-generated pre-prepared lambda bacteriophage replacement vector EMBL3 arms (Promega) followed by packaging in vitro into pre-prepared phage heads and tails (Promega) according to the manufacturer's instructions. Lambda EMBL3 has been shown previously to have a cloning capacity of 9-23 kb (Frischauf et al., 1983) . Following in vitro packaging, recombinant phage particles were propagated on the E . coli P2 lysogenic strain P2 392 as described by Sambrook et al. (1989) .
A recombinant lambda library containing 7.5 x lo4 p.f.u. was obtained. The probability of a given sequence not being contained in the library was calculated as 2 4 x lo-", using the equation of Kurtz et al. (1990) , estimating the C. albicans genome as approximately 29.4 Mb in size and estimating the mean insert size in the library to be approximately 15 kb. Recombinant phages were propagated on E. coli LE392 to yield -600-700 p.f.u. per plate for 10 x 90 mm Petri plates and were transferred from the plaques onto nitrocellulose membrane filters (Schleicher and Schuell) by overlaying the plaques with the filters, which were then screened by plaque hybridization (Sambrook et al., 1989) using the a-32P-labelled cloned amplimer contained in pDB001. The genomic DNA of a recombinant EMBL3 phage, termed P7, which hybridized strongly with the probe was purified as described by Sambrook et al. (1989) . The cloned DNA insert of P7 ( Fig. 1) was mapped with restriction endonucleases and specific fragments were subcloned into pBluescript by conventional methods (Sambrook et al., 1989) .
Pulsed-field gel electrophoresis (PFGE).
Yeast chromosomes were prepared in agarose plugs as described by Vazquez et al. (1991) and were separated in 1.3 ' / o (w/v) agarose gels using the CHEF-Mapper PFGE system (Bio-Rad). The electrophoresis buffer used was 0 5 x TBE and was maintained at 14 "C using buffer recycling through a Bio-Rad minichiller (model 1000). Gels were run for 22 h with an initial switch time of 60 s and a final switch time of 280 s, with a ramping factor of -2-379. Following electrophoresis, gels were stained with 0.5 pg ethidium bromide ml-l for 20 min, destained for between 20 and 90 min in distilled water and viewed on a UV transilluminator. Preparation of cell-free protein extracts from Candida strains and isolates. Cell-free protein extracts from Candida strains and isolates were prepared by mechanical lysis using glass beads. Briefly, separate 50ml volumes of YPD broth were inoculated with 1 x lo5 cells ml-l of each strain or isolate, and placed in a shaking orbital incubator, set at 200 r.p.m., for 20 h at 37 "C, after which time the cultures had a final cell density of approximately 1 x lo8 cells ml-'. The inocula were prepared by diluting cells from 4 h YPD broth cultures in sterile saline to yield the required cell density. Cells were harvested by centrifugation at 5900 g (Sepatech Megafuge 1.0, Heraeus) for 10 min and washed once in sterile saline. Yeast cell pellets were resuspended in 1 ml p-nitrophenylphosphorylcholine (p-NPPC) assay buffer (60 '/o, w/v, sorbitol buffered with 025 M Tris/HCl, pH 7.2; Kurioka & Matsuda, 1976) . This suspension was lysed using 1 g glass beads (045-0-5 mm diameter; Sigma) by vortexing in a Maximix Plus (Thermolyne) vortex using a cycle of 5 x 1 min with 1 min intermittent cooling on ice. The glass beads were then separated by centrifugation for 5 min at l500g and the resulting supernatant was further centrifuged at 10600 g in an Eppendorf centrifuge (model 5417C) for 5 min to yield a cellfree protein extract. The concentration of total protein (mg ml-l) in each extract was determined using a kit based on the Bradford protein assay system (Bio-Rad) used according to the manufacturer's instructions. Preparation of cell-free protein extracts from E. coli strains harbouring pBIuescript and derivatives. The method used to prepare cell free homogenates from E. coli DHSa derivatives harbouring plasmids was essentially that described above for Candida strains and isolates, except that L broth (supplemented with 100 pg ampicillin ml-' to maintain plasmids) was used as growth medium and a lysis cycle of 3 x 1 min with 1 min with intermittent cooling on ice was used. Cell-free supernatants were generated and protein concentrations determined as described above. Spectrophotometric assay of phospholipase C activity.
Candida strains and isolates and E . coli DH5a derivatives harbouring plasmids pBluescript, pDB008, pDBOO9, pDBO10, pDB016 or pDB017 were assayed for PLC activity using the phospholipase-C-specific substrate p-NPPC by a modification of the method described by Kurioka & Matsuda (1976) . Briefly, 90 pl freshly prepared protein extract from each isolate was assayed in 96-well round-bottomed microtitre plates (Corning) by the addition of 10 pl200 mM p-NPPC (20 mM final concn) in 60% (w/v) sorbitol buffered with 0.25 M Tris/HCl (pH 7.2), and incubated at 37 "C for 20 h. The rate of p-NPPC hydrolysis by PLC was determined by measuring free p-nitrophenol at 405 nm using an ELISA plate reader (Spectra I ; SLT-Labinstruments). For each series of test experiments, standard concentrations of PLC (type IX, from Clostridiurn perfringens ; 6.6 units of activity per mg of solid; Sigma) with known units of activity in pg ml-l were assayed in a reaction mixture containing 20 mM p-NPPC, 60% (w/v) sorbitol buffered with 0.25 M Tris/HCl (pH 7.2) at 37 "C for 20 h to generate a standard curve of PLC activity for each experiment. The activity units of PLC (based on concentration) for each isolate tested were calculated from the slope of the standard curve generated in the same experiment. The activity of PLC was expressed as units per mg total protein in cell-free extract for each isolate tested. One unit of activity was defined as the amount of enzyme that will liberate 1.0 pmol p-nitrophenol from p-NPPC min-' at 37 "C, pH 7.2. RNA isolation, reverse transcription and PCR. Total cellular RNA was isolated from 7 h and 24 h C. albicans 132A blastospore cultures grown in YPD broth medium at 37OC and from hyphal cultures grown in Yeast Nitrogen-base Proline medium at 37 "C (NYP; Gallagher et al., 1992) using the procedure of Hube et al. (1994) . Total cellular RNA was also isolated from 7 h YPD broth cultures of the oral isolates C. dubliniensis CD48-I, C. tropicalis 709A, C. glabrata 803A and C. parapsilosis 701A using the same procedure. Total RNA was reverse transcribed in a reaction volume of 2Opl containing 1 mM each of dATP, dGTP, dCTP and dTTP, performed in a Perkin Elmer Cetus DNA thermal cycler. The reactions were essentially those described for DNA PCR (see above) except that reaction mixtures contained 20 pmol of each primer and 8 pl of each cDNA sample was added as template. The primers used were XDOM F and XDOM R (Table 1) . PCR conditions were 35 cycles at 94 "C for 1 min, 55 "C for 1 min and 72 "C for 1 min, followed by a further 10 min at 72 "C. Reaction products were analysed by electrophoresis through 2 % (w/v) agarose gels. In addition to a PCR negative control to which no template was added, other negative controls included reactions in which DNase-treated RNA that had not been reverse transcribed was used as a template for each RNA preparation tested. These controls were used to ensure that RNA preparations used for cDNA synthesis were not contaminated with cellular DNA. Genomic DNA from C. albicans 132A was used as a positive PCR control in each PCR experiment. Two primers, ACT F and ACT R (Table l ) Mannheim) and 500 ng C. albicans 132A total cellular DNA.
The primers used were PLCS2 and PLCE ( Table 1) . After an initial denaturation step of 94 OC for 2 min, PCR conditions were 10 cycles of 94 "C for 10 s, 45 "C for 30 s and 68 "C for 4 min followed by 15 cycles of 94 "C for 10 s, 45 OC for 30 s and 68 "C for 4 min with an extension of 20 s for each cycle at the elongation temperature, followed by a prolonged elongation step of 7 rnin at 68 "C. Reaction products were analysed by electrophoresis through 0.8 % (v/v) agarose gels.
PCR products were purified immediately after amplification by extraction with an equal volume of phenol/chloroform (1 : 1, V/V) followed by precipitation with 0.3 M sodium acetate and 2 vols ice-cold 100% (v/v) ethanol. Aliquots of each purified PCR product were then co-digested with EcoRI and SpeI and cloned into EcoRI-and SpeI-cleaved vector plasmid pBluescript. 
RESULTS AND DISCUSSION

Identification of a C. albicans phospholipase C gene
In an attempt to identify a C. albicans PLC determinant using PCR, a pair of degenerate oligonucleotide primers, termed CAPHO5 and CAPH06 respectively, were designed (Table l) , which were complementary to sequences encoding two non-contiguous conserved amino acid regions from within the X domains of 22 previously characterized phospholipase C (PLC) genes from seven separate eukaryotic species (Table 2 ). The predicted sizes of amplimers which would be obtained with target DNA from these genes ( Table 2 ) using these primers would be approximately 130 bp in each case. Ten PCR products were obtained with target genomic DNA from C. albicans 132A, ranging in size from 100 to 800 bp, four of which were >350 bp. Because the predicted size of amplimers obtainable with the PLC genes listed in Table 2 was much smaller, the four larger C. albicans 132A amplimers were not studied further. Each of the six smaller amplimers was purified and cloned separately into pBluescript, and their nucleotide sequences were determined. The sequence of one amplimer of 130 bp cloned in the recombinant plasmid pDBOOl was found to be highly homologous (65% sequence identity) to the corresponding nucleotide sequence encoding the X domain of the PLC gene of the fission yeast Schiz. pombe (67% predicted amino acid identity, 91 % similarity ; Fankhauser et al., 1995) . Sixtynine basepairs of the 130 bp amplimer cloned in pDBOOl consisted of primer sequences used for amplification ; the deduced amino acid sequence of the remaining 61 bp was 68 YO identical (89 '/ O similar) to residues of the X domain encoded by the Schiz. pombe PLC gene. These data indicated that pDBOOl was likely to encode part of a C. albicans 132A PLC determinant and it was subsequently used as a probe to screen a C. albicans 132A genomic DNA library. None of the remaining five cloned amplimers showed any significant sequence homology to other PLC genes in the GenBank database. The sequence of the amplimer cloned in pDBOOl is indicated in Fig. 2 .
Isolation and physical mapping of a C. albicans phospholipase C gene
Plaques from a C. albicans 132A genomic DNA library constructed in the lambda vector EMBL3 were hybridized with the ~c-~~P-labelled insert from pDBOOl and hybridization signals were obtained which corresponded to seven individual plaques from a total of approximately 7000 screened. The recombinant phage from the plaque yielding the strongest signal was chosen for further study and the phage termed P7. Phage P7 harboured a cloned DNA insert of approximately 18 kb which contained a single internal SaZI restriction site (Fig. 1) . The cloned amplimer in pDBOOl also contained a single internal SaZI site, which indicated that the region of shared DNA homology with the DNA of P7 spanned the internal SaZI site (Fig. 1) . Furthermore, pDBOOl insert DNA hybridized with each of the 4-0 kb SaZI, the 4.5 kb SaZI-X6aI and the 4.5 kb AuaI fragments of P7
following subcloning in pBluescript to yield plasmids pDB003, pDB004 and pDBOO5, respectively (Fig. 1) . This evidence, together with the homology shared between the cloned amplimer DNA in pDBOOl and the Schiz. pombe PLC determinant, suggested that the region of P7 DNA spanning the internal SalI site very probably encoded a PLC determinant from C. aZ6icans
132A. T o investigate this possibility further, the 3.0 kb
AvaI-SpeI fragment of pDBOO5 was subcloned into plasmid pBluescript to yield pDBOO8. The entire nucleotide sequence of the 3.0 kb AuaI-SpeI insert of pDBOO8 was determined; part of it is shown in Fig. 2 .
While subcloning fragments of the insert DNA from phage P7 into pBluescript, recombinant plasmids harbouring only the 4.5 kb AvaI fragment which hybridized with pDBOOl were never recovered. In two separate experiments, AuaI fragments of P7 were ligated into AuaI-digested pBluescript ; following transformation into E. coli DH5a 169 transformants harbouring recombinant plasmids were screened, 19 of which were found to contain the 4-5 kb AvaI fragment in conjunction with an additional 0-5 kb AvaI fragment as in pDBOO5 (Fig. 1) . None of the transformants harboured the 4-5 kb AuaI fragment alone. Attempts to recover pDBOO5 derivatives which had lost the 0-5 kb AvaI fragment following digestion with AvaI followed by ligation and transformation into DH5a-were unsuccessful, despite repeated attempts. Furthermore, recombinant derivatives harbouring the 3-0 kb AvaI-SpeI fragment of pDBOO5 subcloned in pBluescript as in pDBOO8 also contained this 0.5 kb AuaI fragment (Fig.  1) . Nucleotide sequence analysis of this 0.5 kb AuaI fragment showed that it originated from the lambda EMBL3 left arm, corresponding to EMBL3 nucleotides 19 397-19 951 (Frischauf et af., 1983) . Further analysis of the sequence revealed that the two AuaI sites of the 0 5 kb AuaI fragment had different recognition sequences. One of these also functioned as a SmaI cleavage site (recognition sequence CCCGGG ; see Fig.  1 ) and was compatible with an AuaI site in pBluescript. The other AvaI site (recognition sequence ATGCCC) was compatible with the AuaI site of the 3.0 kb AuaI-SpeI fragment of P7 cloned in pDB008 (Fig. 1 ) and was incompatible with both pBluescript AuaI sites (recognition sequences CCCGGG and CTCGAG) . Because the AuaI sites of the 4.5 kb AuaI fragment and of the 3.0 kb AuaI-SpeI fragment cloned in plasmids pDBOO5 and pDBOO8, respectively, were incompatible with both AuaI sites in pBluescript, the 0.5 kb AuaI fragment of EMBL3 DNA, also present in both of these plasmids, acted as a linker to facilitate cloning of the larger fragments, in each case. However, repeated attempts to blunt-end clone the 3.0 kb AuaI-SpeI fragment of pDB008 after filling-in of the AuaI site with the Klenow fragment of DNA polymerase failed, but clones containing the 0.5 kb AuaI fragment of EMBL3 were obtained.
Sequence analysis of the C. albicans 132A Pf C gene
Computer analysis of the entire nucleotide sequence of 3-0 kb AvaI-SpeI fragment from pDB008 revealed an incomplete ORF. To locate the transcription/ translation start site of this ORF the nucleotide sequence of the region of DNA 5' to the AuaI site was determined by primer walking along the cloned DNA insert in pDB003 until an ATG/methionine start codon which was preceded by a stop codon and transcription initiation control sequences was observed. In total, approximately 4 kb of DNA sequence was obtained, which contained one large ORF of 3297 bp, termed CAPLCI. This sequence has been deposited in the EMBL nucleotide sequence database (accession number Y 13975). Sequences identical to the fungal consensus transcriptional control sequences CAAG (potential ribosome-binding site), CT-block and TATAA are located at positions -28 and -31, -81 to -110, and -114 to -118, respectively (Brown 8c Lithgow, 1987) [numbering the sequences in the 5' to 3' direction from the first base (+1) of the translation start codon]. Furthermore, consensus sequences for two potential polyadenylation signals (AATAAA) are located starting at nucleotide 3445 and 3480, 148 and 189 bp, respectively, after the translation termination codon (Fig. 2) .
The CAPLCI ORF has the capacity to encode a protein of 1099 amino acids with 16 predicted glycosylation sites, all asparagine residues, with a predicted molecular mass of 124.6 kDa and a PI of 8-16, which is larger in size compared to &form PI-PLCs of other yeasts, including that of Sacch. eukaryotic species in the GenBank database, including Schiz. pombe (Fankhauser et al., 1995) , Sacch. cerevisiae (Yoko-o et al., 1993) , Dictyostelium discoideum (Drayer & van Haastert, 1992) , Bos taurus (Suh et al., 1988) , Rattus norvegicus (Suh et al., 1988) , Cricetulus griseus (Leonis & Silbert, 1996) , Oryctolagus cuniculus (Milting et al., 1996) and Homo sapiens (Cheng et al., 1995) shows more than 19% overall amino acid identity ( > 32 YO similarity) over the entire protein (Fig. 3) . The predicted CAPLCl protein exhibits many of the features common to other PLCs, especially with &form isoenzymes, including amino acid regions which correspond to the X and Y domains that are important for catalytic activity in other PLCs (Rhee et al., 1989; Rhee & Choi, 1992; Ellis et al., 1993; Yagisawa et al., 1994; Cheng et al., 1995; Essen et al., 1996) . The N-terminal part of the CAPLCl protein preceding the X domain shows < 20 % sequence identity with the predicted amino acid sequences of the eight most similar PLC genes representative of different eukaryotic species and is significantly larger in size in each case, at 568 amino acids in length (the N-termini of the eight most similar PLC genes representative of different eukaryotic species range from between 239 and 445 amino acids in length).
Surprisingly, the N-terminal region of the CAPLCl protein did not contain a recognizable EF-hand domain (putative Ca2+-binding site) using the Motifs program of the GCG Wisconsin software package (Genetics Computer Group, 1994) . Furthermore, no sequence within the CAPLCl protein shared any significant similarity with 45 known EF-hand proteins (R. Kretsinger, personal communication). However, as three-dimensional structure is more conserved than amino acid sequence, an EF-hand domain or else other sequences which perform the same role may still be present within CAPLC1. This finding was unique to the predicted CAPLCl protein, as DNA sequences of all previously characterized eukaryotic PLC genes, including those from yeasts and slime moulds, encoded a relatively conserved 29-residue EF-hand domain sequence (Bairoch & Cox, 1990; Essen et al., 1996) . It has long been known that mammalian PLC61 enzymes have an absolute requirement for Ca2+ for activity and the EFhand domain is thought to be essential for activity (Mitchell, 1992; Nishizuka, 1992; Berridge, 1993) . This has been confirmed for rat brain PLC61, as deletion of approximately one half of the EF-hand domain completely abolished enzyme activity . The precise role of the EF-hand domain is unclear but one possibility is that it may be important in maintaining the C-terminal region in the appropriate three dimensional configuration (Essen et al., 1996) .
The region of CAPLCl corresponding to the X domain is 159 amino acids in size, which is greater than the predicted sizes for this domain of between 137 and 141 amino acids for the other eight most similar PLC genes representative of different eukaryotic species in the GenBank database. This variation in size is due to a stretch of 18-19 additional amino acids located within the CAPLCl X domain which do not align with any residues within the corresponding X domains of all other PLCs (19 residues for yeast PLCs and 18 residues for PLCs from higher eukaryotes) in the EMBL database 
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PLSHYLVSSSHNTYLLEDQLTPSSTEAYIRALCKGCRCL~~PNQE------------------PIIYHGYTFTS 289 PLSHYLVSSSHNTYLLEDPSSTEAYIRALCKGCRCLPSLE------------------PVIYHGYTFTS 239 PLSHYLVSSSHNTYLLEDQLTGPSSTEAYIRALCKGCRCLEL~PNQE------------------PIIYHGYTFTS
P L N K Y F I A S S H N m L L G K Q I A P~~I Q~R C V E I D~~G -------------------PWCHG-FLTS 289 PLSHYLVSSSHNTYLLEDQLTGPSSTEAYIRALCKGCRCL~~PNQE------------------PIIYH~FTS 301 P L S H n V S S S H N m U E D Q L A G P S S T E A Y I R A L C K G C R C L E L D S
* * * . ******* * * * * * * * * * . * . * * * * * . * * *
P I S F A N V I R A I K K F A F I V S P W P L I L S L E I H C S P E C Q I K V V 727 444 A I P L K T V I R V I K K Y A F I T S P Y P L I I S L E I N C N K D N Q K L A S 521 506 M I K F N D V I D A I R K Y A F W S P Y P L F I S L E I H C C P~R Q~~Q~~L~~~~P S P E D L~I L~C 585 351 KILFYDVLRAIRDYAFKASPYPVILSLENHCSLEQQQVMARHLKAILGPMLILDQPL~LPSPEQ~GKILLKGKK 430 362 K I L F C D V L R A I R D Y A F K A S P Y W I L S L E N H C S L E Q Q R V M A R 441 363 K I L F C D V L R A I R D Y A F K A S P Y W I L S L E N H C T L E Q Q R V M A R 442 351 K I L F C D A L R A I R D Y~S P Y W I L S L E N H C S L E Q Q R V M A R 430 301 K I L F C D V V R A I R D Y A F K A S P Y W I L S L E N H C S L E Q Q R V M A R 380
* * * * * * * * *. .* ** *. * * * * * * * 4. Alignment of the predicted amino acid sequence of the X domain of the CAPfC7 gene and the corresponding predicted amino acid sequences of the X domains of the eight most similar PfC genes representative of different eukaryotic species in the GenBank database. The X domain encoded by CAPfC7 contains a novel region consisting of 18-19 amino acid residues, a corresponding region for which is absent from the X domains of the other phospholipases. Amino acid sequences were aligned using the CLUSTAL sequence alignment computer program (Higgins & Sharp, 1988) . The phospholipase residues aligned were as follows: CAPLC1, C. albicans (this study); SCPLC, Sacch. cerevisiae; SPPLC, Schiz. pombe; DDPHOSPHC, Dictyostelium discoideum; CGPLCDl, Cricetulus griseus; RSPLC3A, Rattus norvegicus; HSU09117, Homo sapiens; OCPLCMR, Oryctolagus cuniculus; BTPLC3A, 80s taurus. Asterisks indicate identical residues and dots represent similar residues. Dashes indicate gaps created to obtain alignment. (Fig. 4) . These residues are highly hydrophilic, have a high surface probability (Emini et al., 1985) , have a high chain flexibility (Karplus & Schulz, 1985) and have a high Jameson-Wolf antigenicity index (Wolf et al., 1987) as determined by the Peptidestructure computer program (Genetics Computer Group, 1994) . However, despite these additional amino acid residues the X domain of CAPLCl exhibits more than 42 YO amino acid identity ( > 59 % similarity) to the corresponding X domains of the other eight PLCs indicated in Fig. 4 . The CAPLCl X domain also contains two conserved histidine residues (at positions 579 and 642) which have been shown to be essential for enzyme activity in previously characterized PLCs (Fig. 2) . The X domain also contains conserved asparagine, glutamine, aspartic acid and glutamine residues at positions 580, 609, 611 and 676, respectively, which have been shown to be essential for the binding of calcium in other PLCs ( Fig.   2 ; Essen et al., 1996) . The region of the CAPLCl protein between the X and Y domains is 65 amino acids in length, which is within the range of 48-72 amino acids for the corresponding region of the other PLCs. This region also contains a stretch of 13 threonine residues which do not correspond with any residues within the corresponding regions of the other PLCs.
Q I K F S H V C E T I K A R G F E T S P Y W I L S L E V H C S V P Q Q I M M
The region of CAPLCl corresponding to the Y domain is 121 amino acids in size, which is similar to the predicted size for this domain of 120 amino acids for the other eight PLC genes in the EMBL database (Rhee et al., 1989; Drayer & van Haastert, 1992) . This region exhibited >33 YO identity (> 47% similarity) with the Y domains of the eight most similar PLCs representative of different eukaryotic species in the GenBank database, and contained three residues (a serine at position 823, an arginine at position 852 and a tyrosine at position 854) which have been shown to be conserved in previously characterized PI-PLCs, and which are considered important in determining substrate specificity and for catalysis (Essen et al., 1996; Fig. 2) . Finally, the Cterminal part of &form PLC proteins after the Y domain can vary from 147 to 159 amino acids. The C-terminal part of the CAPLCl is 187 amino acids in size and is < 26 YO homologous ( < 43 YO similar) to the C termini of the other PLC proteins examined
Phenotypic expression of CAPLCl in E. coli
To investigate whether expression of the CAPLCI gene could be detected in E. coli, protein extracts from DH5a containing either pDB017 or pDBOO8 or subclones derived from it were tested for PLC activity using the PLC-specific chromogenic substrate p-NPPC. A previous study has reported the expression of a trypanosomal PLC gene in E . coli (Mensa-Wilmot & Englund, 1992) . Plasmid pDBOl7 contained the entire CAPLCl gene, including putative transcriptional control sequences, cloned on a 3-7 kb fragment amplified from C. albicans 132A template DNA using the primer set PLCS2 and PLCE (Table 1) . Extracts from DH5a-harbouring pDB017 failed to exhibit levels of PLC activity above those detected with extracts of DH5a harbouring pBluescript only. Because the cloned DNA within pDB017 was obtained by PCR amplification, it is possible that misincorporation of single nucleotides could have occurred, leading to premature termination of transcription even though the proofreading polymerase Pwo was included with Taq polymerase during amplification. Similar results were obtained when five 3.7 kb amplimers, recovered in separate experiments with C. albicans 132A target DNA, were cloned in pBluescript and DH5a extracts tested for PLC activity. It is also possible that the CAPLCI putative transcriptional control sequences contained in pDB017 (promoter and ribosome-binding site) do not function efficiently in E. coli.
Extracts from DH5a harbouring pDB008 consistently (seven separate experiments) yielded an approximately twofold higher (mean 2-03 f 0.35 higher) level of activity with the p-NPPC substrate compared to DH5a harbouring pBluescript only. Furthermore, extracts from DH5a harbouring pDB016 (Fig. 1 ) also consistently yielded higher levels of activity, although lower than those obtained with pDBOO8, compared to extracts from DHSa harbouring pBluescript only or pDBOlO (Fig. 1) . In a typical experiment the activity in units (mg protein)-' detected in extracts from DH5a-harbouring (i) pDB017 was 11.7 x (iii) pBluescript was 15.3 x (iv) pDB016 was 23.0 x (v) pDBOO9 was 19-8 x and (vi) pDBOlO was 17.6 x 10-2.-Similar results were obtained regardless of whether IPTG was present or absent from the growth medium, suggesting that the PLC activity expressed from the CAPLCI-encoding plasmids was not under control of the inducible lac promoter of pBluescript. Analysis of the CAPLCI sequences in pDB017, pDBO16, pDBOlO and pDBOO9 revealed that the cloned fragments were not in the correct reading frame to be expressed as fusion proteins with /I-galactosidase.
The above expression studies indicated that the truncated CAPLCI gene (82%) encoded by pDB008 was expressed in E. coli at a low level. Furthermore, recombinant plasmid pDBO16, which encoded a more extensively truncated CAPLCI gene (72% ; Fig. l) , but which retained sequences encoding the X and Y domains of the CAPLCl protein, expressed residual PLC activity in E. coli. These results suggest that the CAPLCl Nterminus is not essential for PLC catalytic activity. Previous studies have shown that the N-terminal 135 amino acids of rat brain PLCG1 and the N-terminal 60 amino acids of bovine brain PLCG1 were not required for activity (catalysis) but were essential for substrate binding (Ellis et al., 1993; Yagisawa et a/., 1994; Cifuentes et al., 1993) . It is likely that the PLC activity detected in E. coli DH5a derivatives harbouring pDB008 or pDB016 was due to expression of a truncated CAPLCl protein, containing a functional catalytic domain in each case. The increased PLC activity detected in extracts of E. coli harbouring pDBOO8 compared to pDB016 could be due to translation of the truncated CAPLCI gene in pDBOO8 and the 0.5 kb AvaI EMBL3 sequence located 5' to these sequences as a fusion protein (see Fig. 1 ). The 0.5 kb AvaI fragment within pDB008 contained an internal TATA sequence and (ii) pDBOO8 was 28.1 x encoded an in-frame methionine putative translational start site 18 bp 5' to the AvaI site within CAPLCI (Fig. 1) . These results, together with similarities in the sequence homology of CAPLCI and in the structural organization of the deduced CAPLCl protein in comparison to other previously characterized PLC genes, provided convincing evidence that CAPLCI encodes a functional PLC determinant.
Plasmid pDB008, encoding 82% of the CAPLCI gene, had an adverse effect on the growth of E. coli DHSa, which may have been due to expression of PLC activity. In eleven separate experiments the final cell density of 20 h L-broth cultures of DH5a harbouring pDBOO8 was approximately half that obtained with DH5a harbouring pBluescript only under the same experimental conditions. In seven separate experiments the protein concentration (mg ml-') in cell-free extracts from 20 h cultures of DH5a harbouring pDB008 was consistently more than twofold lower (mean 2.36 f 0-5 fold lower) compared to extracts from cells harbouring pBluescript only. In a typical experiment the protein concentration determined from cell extracts of DH5a harbouring pDB008 was 2.13 mg ml-' compared to 5.02 mg ml-' for DH5a harbouring pBluescript only. No significant difference was observed in the corresponding cell densities or protein concentrations of cell extracts of DH5a harbouring pDB017, pDBO16, pDBOO9, pDBO10, pBluescript or pBluescript derivatives containing the 0.5 kb AvaI fragment of EMBL3 obtained following blunt-end cloning.
Extracts of E. coli DH5a harbouring only pBluescript exhibited levels of PLC activity [ 15 & 0.4 x units (mg protein)-'] ( m e a n k s~, n = 7) which were similar to those detected with extracts of C. albicans 132A Cl5.1 f 1.8 x units (mg protein)-']. The levels of PLC activity detected in the former extracts were higher than but of the same order of magnitude as the sum of PLC activities previously reported in three membrane fractions of E. coli strain B using a radiometric assay (Bayer & Bayer, 1985) .
Expression of CAPLCl in C. albicans
T o detect expression of the CAPLCI gene in C. albicans and to determine whether the sequences encoding the novel stretch of 19 amino acids in the X domain of the deduced translation product were expressed, a pair of primers termed XDOM F and XDOM R, respectively (Table l) , which were complementary to sequences flanking this region were made. These primers were designed to amplify a 210 bp amplimer encoding a 202 bp region of CAPLCI DNA (the remaining 8 bp consisted of primer clamp sequences and restriction sites ; Table 1 ) corresponding to nucleotides 1750-1959 as shown in Fig. 2 . These primers yielded a single amplimer of 210 bp following PCR amplification with target genomic DNA from C. albicans 132A. If the sequences encoding the novel stretch of 18-19 amino acids in the CAPLCl X domain were expressed, a product of 210 bp would be expected when cDNA from C. albicans 132A was used as a PCR template; otherwise a shorter product of 156 bp would be expected. Following PCR amplification of cDNA made from 7 h and 24 h cultures of organisms grown in both the yeast and hyphal forms, a single amplimer of 210 bp was obtained in each case (Fig. 5a) . No amplimers were obtained in control experiments from which reverse transcriptase was omitted. This result demonstrated that the 210 bp PCR product obtained was amplified from mRNA template reverse transcribed as cDNA and not from contaminating DNA. The 210 bp product hybridized strongly to the cloned DNA from pDB016 (encoding 72% of the CAPLCI gene; Fig. 1 ) in subsequent Southern hybridization experiments. These data demonstrated that the CAPLCI gene is expressed in C. albicans 132A, that sequences encoding the unusual stretch of 18-19 amino acids within the CAPLCl X domain are transcribed and that the gene is expressed in both the yeast and hyphal forms of the organism. This finding rules out the possibility that the DNA sequences encoding this region constitute an intron. The possibility that the unique stretch of 18-19 amino acid residues is removed from the CAPLCl protein by intein-mediated post-translational modification was considered unlikely because it is too short to be an intein and does not contain any of the recognized motifs thought to be involved in splicing activity (Perler et al., 1994; F. Perler, personal communication) .
T o determine the size of the CAPLCI mRNA transcript in C. albicans 132A, total RNA was isolated from the yeast and hyphal forms of the organism following 7 h and 20 h growth, in each case, and Northern hybridization experiments were performed using the CAPLC gene from pDB017 as a probe. No transcripts that hybridized with the probe were detected in each of ten separate experiments with separate preparations of RNA. In positive control experiments RNA was probed with a portion of the gene encoding elongation factor 3 (TEF3), and TEF3 mRNA signals were detected from all cultures. Since TEF3 mRNA is expressed under most conditions in yeast and hyphal forms of C. albicans (Swoboda et al., 1994) , these results suggested that CAPLCI mRNA is expressed at very low levels under the conditions tested, and not detectable by Northern analysis. That CAPLCI expression does occur under the conditions tested was demonstrated by the RT-PCR experiments described above, although it should be noted that this technique is immensely more sensitive than Northern blotting. It is possible that expression of CAPLCI occurs at higher levels under conditions we have not tested such as during infection in vivo.
Hybridization analysis of C. albicans with CAPLCl
T o demonstrate that the cloned DNA contained in recombinant plasmids pDBOOl and pDB008 was derived from C. albicans 132A, hybridization analysis was performed using the insert DNA from both plasmids separately on C. albicans 132A total cellular DNA which had been digested with EcoRI only, with AvaI only, and with AvaI and SpeI. Each probe hybridized specifically to a single 20 kb EcoRI fragment, a 4.5 kb AvaI fragment, and a 3.0 kb AvaI-SpeI fragment, respectively (the data obtained with EcoRI-digested DNA and with AvaI-and SpeI-cleaved DNA using the pDB008 insert as a probe are shown Fig. 6a, b, lane 5) . These results confirmed that the CAPLCI DNA cloned in pDB008 is derived from C. albicans 132A and is present as a single copy per genome equivalent.
EcoRI-digested genomic DNA from 26 separate C. albicans oral isolates was also examined by hybridization analysis using the pDB008 insert as a probe. For 14 of the isolates, the probe hybridized to a single band of approximately 20 kb with EcoRI-digested DNA similar to that obtained with C. albicans 132A, whereas 10 isolates yielded a band of approximately 15 kb in addition to a 20 kb hybridization band (Fig. 6a,  lanes 1 and 3) . The remaining two isolates yielded a single EcoRI hybridization band of 15 kb in each case (data not shown). AvaI-and SpeI-digested genomic DNA from 10 of the C. albicans oral isolates from AIDS patients included in the study yielded three hybridization profiles with the probe. Seven of the isolates yielded a single hybridization band of 3.0 kb similar to C. albicans 132A, one isolate yielded a 3.0 kb band and an additional 6.0 kb band and the remaining two isolates yielded three hybridization bands of 3-0 kb, 1.8 kb and 1.2 kb, respectively (Fig. 6b) . These results indicated that in the majority of the oral isolates tested the location of EcoRI, AvaI and SpeI cleavage sites flanking the CAPLCI gene were similarly arranged to C. albicans 132A. However, in some isolates polymorphisms in the sizes of CAPLClencoding restriction fragments affecting only one of the CAPLCI gene homologues in each case had occurred. Similar polymorphisms have been previously reported for the C. albicans LZPl gene family (Fu et al., 1997) .
T o determine if an X domain containing the 'unique' stretch of 18-19 amino acid residues was encoded by other C. albicans strains, the XDOM primer set used in the RT-PCR experiments was applied to target genomic DNA from the 15 C. albicans oral isolates from AIDS patients. Following PCR amplification a single product of approximately 210 bp was observed in each case, similar to the result obtained with C. albicans 132A (data not shown). These findings demonstrated that the presence of the unique stretch of 18-19 residues was a consistent feature in C. albicans isolates.
C. albicans 132A chromosomes separated by PFGE were also hybridized with the 3.0 kb AuaI-SpeI CAPLClencoding cloned DNA from pDB008. The probe hybridized to a single chromosome band approximately 1.02 Mb in size (data not shown), which corresponded to C. albicans chromosome no. 7 according to the numbering system described by Magee et al. (1988 Magee et al. ( , 1992 .
Analysis of CAPLCl homologous sequences in
Candida species other than C. albicans EcoRI-digested and AvaI-and SpeI-digested genomic DNA from eight non-C. albicans Candida species was tested for homology to CAPLCI by hybridization analysis with the 3.0 kb CAPLCI-encoding insert DNA from pDB008. Using identical high-stringency hybridization conditions (i.e. hybridization temperature of 68 "C) to those used with the C. albicans isolates no or very weak hybridization signals were detected with isolates of other non-C. albicans Candida species, including C. dubliniensis ( n = lo), C. tropicalis ( n = S), C. glabrata (n = ll), C. parapsilosis (n = 2), and one isolate each of C. kefyr, C. krusei, C. guillermondii and C. lusitaniae. However, when experiments were repeated at a lower hybridization temperature (60 "C), weak hybridization signals were detected with all 10 C. dubliniensis isolates tested, three C. tropicalis isolates, one C. glabrata isolate and one C. parapsilosis isolate but with none of the C. kefyr, C. krusei, C. guillermondii and C. lusitaniae isolates. Nine of the C. dubliniensis isolates tested each yielded a single EcoRI hybridization band of approximately 20 kb and a single AuaIISpeI hybridization band of 3.5 kb (Fig. 6c) . The remaining C. dubliniensis isolate, CD46, yielded a single EcoRI hybridization band of 15 kb and two weak AuaIISpeI hybridization bands of approximately 3.2 and 4 8 kb, respectively (Fig. 6c) . All three C. tropicalis isolates (709A, 803B and 915B), the C. glabrata isolate (803A) and the C. parapsilosis isolate (701A) which hybridized with the probe yielded single EcoRI hybridization bands, in each case, of approximately 8 kb, 3 kb and 6 kb, respectively and single AuaIISpeI hybridization bands, in each case, of 3.4 kb, 3 4 kb and 2-8 kb, respectively (Fig. 6c) . These findings suggest that the isolates which yielded weak hybridization signals contained CAPLCIhomologous sequences.
T o further explore the relationship between the C. albicans CAPLCI gene and the homologous sequences detected in the non-C. albicans Candida species tested, the degenerate primers originally used to PCR amplify sequences encoding part of the X domain from genomic DNA of C. albicans 132A (Table 1) were applied to target genomic DNA from C. dubliniensis CD48-I, C. glabrata 803A, C. parapsilosis 701A and C. tropicalis 709A, all of which hybridized previously with the CAPLCI probe. Following PCR amplification, several amplimers were obtained from each target DNA sample, one of which of 130 bp in each case hybridized with the CAPLCI DNA of pDB008 (data not shown). Following purification, the 130 bp amplimer from each of the three non-C. albicans isolates tested, excluding C. parapsilosis, was cloned in pBluescript and its nucleotide sequence determined. Repeated attempts to clone the 130 bp product amplified from C. parapsilosis target DNA failed. For each amplimer, the sequence of 61 bases internal to primer sequences was aligned with the corresponding sequence previously amplified from C. albicans 132A (Fig. 7a) . The sequences of the cloned amplimers from the C. dubliniensis, C. glabrata and C. tropicalis isolates showed extensive nucleotide homology with the corresponding sequence from C. albicans and with the corresponding sequences of PLC genes previously characterized from Sacch. cereuisiae and Schiz. pombe (Fig. 7a) . This finding was hardly surprising as the region of DNA amplified and sequenced encoded for part of the highly conserved X domain region of PLC proteins which is essential for catalytic activity.
Genomic DNA from a representative isolate of each non-C. albicans Candida species which did not hybridize with the CAPLCl probe was also used as a template for PCR amplification using the CAPHO primer set. Following PCR amplification, while several amplimers were obtained from each target DNA sample, none in each case hybridized with the CAPLCI DNA of plasmid pDBOO8 (data not shown). This result confirmed that some but not all isolates of the same species possessed a CAPLCl -homologous sequence. The variability in the presence of detectable CAPLCI -homologous sequences in isolates of C. tropicalis, C. glabrata and C. parapsilosis was very surprising. The reasons for this are unknown but it could be due to loss of common sequences following genetic rearrangements or deletion events. Failure to detect CAPLCI -homologous sequences by hybridization analysis correlated with failure to amplify CAPLCI -homologous sequences using PCR. This latter finding suggests the total absence of CAPLCI-homologous sequences or that significant differences occur in the sequence composition of PLC genes in particular isolates of non-C. albicans Candida species which failed to hybridize with the CAPLCI probe. albicans 132A and C. dubhiensis CD48-I using the XDOM primer set (Table 1 ). These primers were specifically designed to amplify the region of DNA (210 bp) which encoded the novel stretch of 18/19 amino acids (residues underlined) present in CAPLCl X domain. The XDOM primers amplified a CAPLCI-homologous PCR product of 180 bp with genomic DNA from C. dubhiensis CD48-I. The nucleotide sequence of this region from C. dubhiensis only encoded for 11 amino acids in the region corresponding to the C. albicans novel stretch of amino acids. Asterisks indicate identical residues and dots represent similar residues. Dashes indicate gaps created to obtain alignment. Residue co-ordinates shown on the left of the figure for CAPLCl are numbered as in Fig. 2 . The percentage identity of the aligned sequences is shown on the right.
T G G T C G A C A A G~T " C A ' I C A G T A G A A G G G T A T A T A C~a W A~~T C. dubliniensis CD48-I (CDPLCI)
Chromosome-sized DNA molecules from C. tropicalis 709A, C. glabrata 803A, C. parapsilosis 701A and C. dubliniensis CD48-I and CD46 were separated by PFGE and were hybridized with the CAPLCI DNA of plasmid pDB008 (data not shown). The probe hybridized to single chromosome bands of approximately 1.2 Mb, 1.1 Mb and 1-0 Mb in C. tropicalis 709A, C. glabrata 803A and C. parapsilosis 701A, respectively. However, the probe hybridized to two chromosome bands each in the two C. dubliniensis isolates, a 1.0 Mb and a 2.2 Mb band in isolate CD46, and a 1-2 Mb and a 2.2 Mb band in isolate CD48-I. It is possible that the pattern observed in both C. dubliniensis isolates is a result of chromosome fragmentation, a phenomenon which has previously been observed in other C. dubliniensis karyotype profiles D. Sullivan & D. C. Coleman, unpublished data) .
Because all 10 of the C. dubliniensis isolates included in the study hybridized with CAPLCI and because previous studies have shown that C. dubliniensis is the species phylogenetically most closely related to C. albicans (Sullivan et al., 1995 (Sullivan et al., , 1996 , experiments were performed to determine whether the C. dubliniensis sequences homologous to CAPLCI encoded a similar novel stretch of amino acids as detected within the X domain of the C. albicans CAPLCl protein (Fig. 4) . The XDOM primer set, which was complementary to sequences encoding this region in C. albicans 132A (Table l) , was used to amplify sequences from C. dubliniensis CD48-I and CD46 DNA. Two amplimers, of approximately 180 bp and 380 bp, respectively, were obtained in each case, only the smaller of which hybridized with the CAPLCI -encoding DNA from pDB008. Both amplimers from C. dubliniensis CD48-I were purified, cloned in pBluescript and their nucleotide sequences determined. The deduced amino acid sequence of the larger amplimer (359 bp) exhibited no homology with any previously characterized PLC gene in the GenBank database (analysis performed in March 1997), whereas that of the smaller amplimer (179 bp) shared 80-6 YO overall amino acid identity (82.1 YO similarity) with the corresponding C. albicans sequence (Fig. 7b) . However, the C. dubliniensis sequence only encoded 11 amino acids in the region corresponding to the C. albicans ' novel ' stretch of 19 residues, only six of which were identical and one similar to the corresponding C. albicans sequence (Fig. 7b) .
T o determine whether the CAPLCI -homologous sequences detected in non-C. albicans Candida species by hybridization and PCR analyses were expressed as mRNA, RT-PCR experiments were performed on total cellular RNA from 24 h broth cultures of one isolate of C. dubliniensis, and one isolate in each case of those C. tropicalis, C. glabrata and C. parapsilosis isolates which exhibited CAPLCZ homology. Amplimers of similar size to those obtained with C. dubliniensis CD48-I, C. tropicalis 709A, C. parapsilosis 701A genomic DNA were also obtained when cDNA made from these isolates was used as a PCR template with the XDOM primer set (Fig. 5b) . These findings showed that C. dubliniensis, C. tropicalis and C. parapsilosis CAPLClassociated DNA was present as mRNA transcripts and was therefore expressed. mRNA was also found to be present in C. dubliniensis isolate CD48-I following growth in both the yeast and hyphal phases at both 7 h and 24 time intervals, in each case (Fig. 5a) . However, no amplimer was detected with cDNA from C . glabrata 803A. An amplimer of the expected size (440 bp) was obtained when the same cDNA preparation from C. glabrata 803A cDNA was used as a PCR template with the ACT primer set (Table 1 ) which served as a positive control for cDNA synthesis and RT-PCR (Fig. 5b) . This suggested that the C. glabrata 803A CAPLCZ -associated DNA sequence was not present as an mRNA transcript and was therefore not expressed under the conditions used.
Phospholipase C activity of Candida species
All of the Candida isolates used in hybridization experiments were tested for PLC activity using p-NPPC 
Concluding remarks
We have described the genetic characterization of the first PLC gene, termed CAPLCZ, to be cloned from the pathogenic yeast C. albicans. With the development of efficient gene-targeting systems in C. albicans it is possible to use cloned DNA sequences to generate null mutants of specific genes (Fonzi & Irwin, 1993; Gow et al., 1994) and to study non-lethal mutations (Brown et al., 1996) . The precise role of the CAPLCZ gene in C. albicans is unknown; however, based on sequence homology with previously characterized PLCG1 genes from other yeasts and from higher eukaryotes and the presence of conserved regions within the predicted CAPLCl protein, it is likely that CAPLCl is involved in signal transduction. The presence of CAPLCZ -related sequences in several non-C. albicans Candida species also indicated that these species contain PLC genes, which very probably perform a similar function to 
